Trial Outcomes & Findings for Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer (NCT NCT02821793)
NCT ID: NCT02821793
Last Updated: 2025-07-01
Results Overview
Prioritization among of the 4 items selected from a list of 8 expectations regarding the objectives of their treatment : treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden. For each expectation, the number and rate of priorization are reported.
Recruitment status
COMPLETED
Target enrollment
346 participants
Primary outcome timeframe
Day 0 initiation of treatment
Results posted on
2025-07-01
Participant Flow
Recruitment from January 2016 to January 2022 in 8 centers.
Elderly patients (≥ 70 years of age) were recruited by the investigating oncologists or geriatricians at organ-specific multidisciplinary consultation meetings (RCP) or during consultations. Younger patients were identified and recruited in the same way, mainly through RCP or specialized consultation by oncologists.
Participant milestones
| Measure |
Elderly Patient (70 Years and Older)
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Overall Study
STARTED
|
246
|
100
|
|
Overall Study
Major Deviation From Protocol
|
13
|
0
|
|
Overall Study
Major Deviation on Eligibility Criteria
|
6
|
1
|
|
Overall Study
COMPLETED
|
227
|
99
|
|
Overall Study
NOT COMPLETED
|
19
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Elderly Patient (70 Years and Older)
n=227 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=99 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
Total
n=326 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
79.2 years
n=227 Participants
|
61.3 years
n=99 Participants
|
75.9 years
n=326 Participants
|
|
Sex: Female, Male
Female
|
149 Participants
n=227 Participants
|
71 Participants
n=99 Participants
|
220 Participants
n=326 Participants
|
|
Sex: Female, Male
Male
|
78 Participants
n=227 Participants
|
28 Participants
n=99 Participants
|
106 Participants
n=326 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
France
|
227 participants
n=227 Participants
|
99 participants
n=99 Participants
|
326 participants
n=326 Participants
|
PRIMARY outcome
Timeframe: Day 0 initiation of treatmentPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid at the initiation of treatment
Prioritization among of the 4 items selected from a list of 8 expectations regarding the objectives of their treatment : treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden. For each expectation, the number and rate of priorization are reported.
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=211 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=97 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Treatment efficacy
|
199 Participants
|
93 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Life expectancy
|
141 Participants
|
80 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Autonomy
|
181 Participants
|
67 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Daily tasks
|
115 Participants
|
44 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Social activities
|
80 Participants
|
47 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Burden of treatment
|
47 Participants
|
17 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Toxicity
|
66 Participants
|
35 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer at Treatment Initiation
Economic burden
|
13 Participants
|
5 Participants
|
PRIMARY outcome
Timeframe: 3 months after initiation of treatmentPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid 3 months after initiation of treatment
Prioritization among of the 4 items selected from a list of 8 expectations regarding the objectives of their treatment : treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden. For each expectation, the number and rate of priorization are reported.
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=155 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=88 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Economic burden
|
15 Participants
|
7 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Treatment efficacy
|
145 Participants
|
85 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Life expectancy
|
105 Participants
|
72 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Autonomy
|
134 Participants
|
66 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Daily tasks
|
93 Participants
|
44 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Social activities
|
69 Participants
|
46 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Burden of treatment
|
27 Participants
|
8 Participants
|
|
Priorities of Patients Receiving First Medical Treatment for Cancer 3 Months After Initiation of Treatment
Toxicity
|
30 Participants
|
22 Participants
|
SECONDARY outcome
Timeframe: Day 0 initiation of treatmentPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid at the initiation of treatment
Patients had to rate on a 5-point Likert scale (not at all / a little / moderately / quite / a lot) their expectations for treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=211 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=97 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · Not at all
|
3 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · A little
|
4 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · Moderately
|
5 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · Quite
|
24 Participants
|
4 Participants
|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · A lot
|
173 Participants
|
91 Participants
|
|
Expectations of Patients at Initiation of Treatment
Treatment efficacy · Missing
|
2 Participants
|
2 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · Not at all
|
4 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · A little
|
5 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · Moderately
|
23 Participants
|
2 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · Quite
|
38 Participants
|
8 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · A lot
|
139 Participants
|
85 Participants
|
|
Expectations of Patients at Initiation of Treatment
Life expectancy · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · Not at all
|
2 Participants
|
2 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · A little
|
0 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · Moderately
|
7 Participants
|
3 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · Quite
|
23 Participants
|
16 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · A lot
|
178 Participants
|
75 Participants
|
|
Expectations of Patients at Initiation of Treatment
Autonomy · Missing
|
1 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · Not at all
|
4 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · A little
|
9 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · Moderately
|
23 Participants
|
3 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · Quite
|
37 Participants
|
19 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · A lot
|
136 Participants
|
74 Participants
|
|
Expectations of Patients at Initiation of Treatment
Daily tasks · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · Not at all
|
5 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · A little
|
12 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · Moderately
|
21 Participants
|
4 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · Quite
|
36 Participants
|
19 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · A lot
|
135 Participants
|
74 Participants
|
|
Expectations of Patients at Initiation of Treatment
Social activities · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · Not at all
|
6 Participants
|
6 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · A little
|
6 Participants
|
4 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · Moderately
|
25 Participants
|
8 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · Quite
|
49 Participants
|
24 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · A lot
|
124 Participants
|
55 Participants
|
|
Expectations of Patients at Initiation of Treatment
Burden of treatment · Missing
|
1 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · Not at all
|
4 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · A little
|
4 Participants
|
0 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · Moderately
|
17 Participants
|
8 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · Quite
|
40 Participants
|
16 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · A lot
|
144 Participants
|
71 Participants
|
|
Expectations of Patients at Initiation of Treatment
Toxicity · Missing
|
2 Participants
|
1 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · Not at all
|
28 Participants
|
17 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · A little
|
15 Participants
|
6 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · Moderately
|
34 Participants
|
13 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · Quite
|
35 Participants
|
16 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · A lot
|
92 Participants
|
45 Participants
|
|
Expectations of Patients at Initiation of Treatment
Economic burden · Missing
|
7 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 3 months after initiation of treatmentPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid 3 months after initiation of treatment
Patients had to rate on a 5-point Likert scale (not at all / a little / moderately / quite / a lot) their expectations for treatment efficacy, life expectancy, autonomy, daily tasks, social activities, burden of treatment, toxicity and economic burden
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=155 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=88 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · Not at all
|
2 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · A little
|
11 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · Moderately
|
17 Participants
|
4 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · Quite
|
38 Participants
|
23 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · A lot
|
87 Participants
|
58 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Daily tasks · Missing
|
0 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · Not at all
|
9 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · A little
|
14 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · Moderately
|
20 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · Quite
|
34 Participants
|
22 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · A lot
|
76 Participants
|
61 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Social activities · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · Not at all
|
16 Participants
|
7 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · A little
|
13 Participants
|
4 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · Moderately
|
23 Participants
|
13 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · Quite
|
41 Participants
|
26 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · A lot
|
62 Participants
|
38 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Burden of treatment · Missing
|
0 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · Not at all
|
14 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · A little
|
4 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · Moderately
|
14 Participants
|
8 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · Quite
|
43 Participants
|
25 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · A lot
|
80 Participants
|
51 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Toxicity · Missing
|
0 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · Not at all
|
31 Participants
|
22 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · A little
|
15 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · Moderately
|
10 Participants
|
11 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · Quite
|
30 Participants
|
23 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · A lot
|
67 Participants
|
31 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Economic burden · Missing
|
2 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · Not at all
|
1 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · A little
|
5 Participants
|
4 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · Moderately
|
9 Participants
|
5 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · Quite
|
23 Participants
|
10 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · A lot
|
115 Participants
|
68 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Treatment efficacy · Missing
|
2 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · Not at all
|
4 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · A little
|
9 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · Moderately
|
18 Participants
|
2 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · Quite
|
31 Participants
|
14 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · A lot
|
91 Participants
|
70 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Life expectancy · Missing
|
2 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · Not at all
|
2 Participants
|
1 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · A little
|
2 Participants
|
0 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · Moderately
|
5 Participants
|
3 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · Quite
|
18 Participants
|
19 Participants
|
|
Expectations of Patients 3 Months After Initiation of Treatment
Autonomy · A lot
|
126 Participants
|
65 Participants
|
SECONDARY outcome
Timeframe: 3 months after initiation of treatmentPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid at the initiation of treatment and 3 months after treatment initiation
For each expectation, stability is defined as the prioritization of the expectation at treatment initiation and 3 months after treatment initiation
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=155 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=88 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Stability of Patients in Their Priorities at 3 Months
Treatment efficacy
|
137 Participants
|
82 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Life expectancy
|
74 Participants
|
62 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Autonomy
|
119 Participants
|
51 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Daily tasks
|
59 Participants
|
24 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Social activities
|
35 Participants
|
25 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Burden of treatment
|
8 Participants
|
1 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Toxicity
|
11 Participants
|
15 Participants
|
|
Stability of Patients in Their Priorities at 3 Months
Economic burden
|
2 Participants
|
1 Participants
|
SECONDARY outcome
Timeframe: From inclusion to the end of studyPopulation: Patients without major deviation on study protocol and eligibility criteria who indicated at least one priority in the prioritization grid at the initiation of treatment
Overall survival is defined as the time between the date of inclusion and the date of death, whatever the cause. The rate of overall survival is reported at 1 year
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=211 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=97 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
1-year Overall Survival
|
77.5 percentage of patient
Interval 71.4 to 83.0
|
85.2 percentage of patient
Interval 76.2 to 90.9
|
SECONDARY outcome
Timeframe: Day 0 initiation of treatmentPopulation: Patients without major deviations from study protocol and eligibility criteria who indicated at least one priority in the prioritization grid at treatment initiation and whose physician also indicated at least one priority in the prioritization grid.
For each expectation, the agreement rate is defined by the same prioritization or non-prioritization by the patient-physician pairs.
Outcome measures
| Measure |
Elderly Patient (70 Years and Older)
n=200 Participants
Geriatric consultation, evaluation questionnaire: Geriatric consultation, evaluation questionnaire
|
Young Patient (18 Years - 69 Years)
n=97 Participants
Consultation, evaluation questionnaire: Consultation, evaluation questionnaire
|
|---|---|---|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Treatment efficacy
|
174 Participants
|
84 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Life expectancy
|
123 Participants
|
76 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Autonomy
|
128 Participants
|
47 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Daily tasks
|
100 Participants
|
45 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Social activities
|
122 Participants
|
52 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Burden of treatment
|
110 Participants
|
47 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Toxicity
|
91 Participants
|
46 Participants
|
|
Agreement Rate for Prioritization of Expectations Between Patients and Physicians
Economic burden
|
186 Participants
|
93 Participants
|
Adverse Events
Elderly Patient (70 Years and Older)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 47 deaths
Young Patient (18 Years - 69 Years)
Serious events: 0 serious events
Other events: 0 other events
Deaths: 17 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place